Next phases of breast cancer drug research coming to RI

Via Peters

PROVIDENCE, R.I. (WPRI) — Advancements in a drug targeting breast cancer growth have oncologists hopeful about potential treatment options for patients with advanced forms of the disease. Results from the DESTINY-Breast04 Phase III trial showed the intravenous drug Enhertu, also known as trastuzumab deruxtecan, demonstrated “superior and clinically meaningful” progression-free and […]

Global Breast Cancer Treatment Drugs Market Report, Growth Insight, Deep Research & Segment Analysis

Via Peters

Global “Breast Cancer Treatment Drugs Market” Reports 2022 provide key industry studies for Breast Cancer Treatment Drugs manufacturers with specific statistics, significance, definition, SWOT analysis, expert opinion and the latest developments in the world. The research report also covers market size, price, sales, revenue, market shares, gross margin, growth rate […]

Evidence for Practice and Research Recommendations

Via Peters

This review article written by Danielle Gentile, PhD, et al, reviews the management of cancer-related fatigue in integrative oncology. ABSTRACT Cancer-related fatigue (CRF) is one of the most common symptoms across the cancer continuum and is often underreported and undertreated. Defined as a distressing, persistent, subjective sense of tiredness or […]

New research suggests ways to get men to open up

Via Peters

UBCO research shows that finding ways to anchor mental health promotion in a lifestyle intervention such as team sports, hobbies or other interests encourages men to seek out and engage in health services. While the stereotypical image of the sullen male suffering in silence still rings true in many places, […]

Antidepressant Drug Use in Patients With T2D Lacks Research

Via Peters

Researchers published the study covered in this summary on medRxiv.org as a preprint that has not yet been peer reviewed. Key Takeaways The authors of this systematic review attempted to assess and synthesize the long-term outcomes from observational studies of people with type 2 diabetes and comorbid depression who received […]